
ASND
240.52 USD
-0.16%
Today
+0.03%
1D
Last seen at Tue, 10 Mar 2026 22:35:00 GMT+3
Market is closed
Sun
Closed
Mon
3:31 PM ~ 9:59 PM
Tue
3:31 PM ~ 9:59 PM
Wed
3:31 PM ~ 9:59 PM
Thu
3:31 PM ~ 9:59 PM
Fri
3:31 PM ~ 9:59 PM
Sat
Closed
Performance
1 Day
+ 0.03 %
1 Week
+ 0.95 %
1 Month
+ 9.89 %
3 Month
+ 24.47 %
6 Month
+ 19.57 %
1 Year
+ 76.37 %
Information
Name
Ascendis Pharma A/S Leveraged
Currency
USD
Standard Leverage
1X
Enhanced Leverage
3X
Overnight Fees Buy
-0.0191%
Overnight Fees Sell
0.0024%
Market Cap
14.68B
Avg Daily Volume
809.08K
52 Week High
248.6 USD
52 Week Low
124.06 USD
Trading Hours
See hours
Overnight Fees Calculator
| Daily Overnight Fee % | Daily Overnight Fee $ | |
|---|---|---|
| BUYS | -0.01910% | $(0.191) |
| SELLS | 0.00240% | $0.024 |
*Results displayed are estimates. Actual fees may differ from those shown as market conditions change.
Business Summary
Ascendis Pharma A/S, operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Europe, the United States, and internationally. The company offers SKYTROFA for treating pediatric patients with growth hormone deficiency; and YORVIPATH, a once-daily subcutaneous injection for the treatment of adults with chronic hypoparathyroidism. It is also developing a pipeline of three independent endocrinology rare disease product candidates in clinical development, as well as focuses on advancing oncology therapeutic candidates. The company was incorporated in 2006 and is based in Hellerup, Denmark.
Top News
Ascendis Pharma to Participate in the TD Cowen 46th Annual Health Care Conference
tradingview.com
1w ago

FDA Approves Once-Weekly YUVIWEL® (navepegritide) for Children with Achondroplasia Aged 2 Years and Older
tradingview.com
1w ago

Entera Bio Heads Toward Phase 3 With EB613 in a 200 Million-Woman Osteoporosis Market (NASDAQ: ENTX)
tradingview.com
2w ago

Show more
Frequently Asked Questions
What are healthcare stocks and why are they important to investors?
Healthcare stocks include pharmaceutical companies, biotech firms, hospitals, and medical device manufacturers.
Are healthcare stocks less volatile?
Generally yes. Because healthcare is a necessity, demand remains relatively steady, making the sector less sensitive to economic cycles.
What drives growth in healthcare investments?
Aging populations, technological advancements, and increased healthcare spending contribute to long-term growth in the sector.
What are the risks of investing in healthcare?
Regulatory changes, drug approval delays, and legal challenges can affect the profitability and stock prices of healthcare companies.



